中国医药科学
中國醫藥科學
중국의약과학
CHINA MEDICINE AND PHARMACY
2014年
20期
193-195
,共3页
复合辅酶%鼻咽癌%放化疗%毒副反应
複閤輔酶%鼻嚥癌%放化療%毒副反應
복합보매%비인암%방화료%독부반응
Coenzyme complex%Nasopharynx cancer%Chemoradiotherapy%Toxic and side effect
目的:探讨复合辅酶减轻鼻咽癌放化疗毒副反应的临床效果。方法按照随机数字表法将我院收治的80例中晚期鼻咽癌患者分为实验组和对照组,实验组在放化疗综合治疗基础上给予复合辅酶治疗,对照组仅给予放化疗综合治疗,比较两组患者近期疗效及毒副反应发生情况。结果两组患者近期疗效比较,差异无统计学意义(P>0.05);实验组患者口咽黏膜反应、胃肠道反应、骨髓抑制及照射野皮肤反应等毒副反应严重程度均显著低于对照组,差异有统计学意义(P<0.05)。结论复合辅酶辅助治疗鼻咽癌可有效减轻放化疗毒副反应,对提高患者生活质量和治疗耐受性均有积极意义。
目的:探討複閤輔酶減輕鼻嚥癌放化療毒副反應的臨床效果。方法按照隨機數字錶法將我院收治的80例中晚期鼻嚥癌患者分為實驗組和對照組,實驗組在放化療綜閤治療基礎上給予複閤輔酶治療,對照組僅給予放化療綜閤治療,比較兩組患者近期療效及毒副反應髮生情況。結果兩組患者近期療效比較,差異無統計學意義(P>0.05);實驗組患者口嚥黏膜反應、胃腸道反應、骨髓抑製及照射野皮膚反應等毒副反應嚴重程度均顯著低于對照組,差異有統計學意義(P<0.05)。結論複閤輔酶輔助治療鼻嚥癌可有效減輕放化療毒副反應,對提高患者生活質量和治療耐受性均有積極意義。
목적:탐토복합보매감경비인암방화료독부반응적림상효과。방법안조수궤수자표법장아원수치적80례중만기비인암환자분위실험조화대조조,실험조재방화료종합치료기출상급여복합보매치료,대조조부급여방화료종합치료,비교량조환자근기료효급독부반응발생정황。결과량조환자근기료효비교,차이무통계학의의(P>0.05);실험조환자구인점막반응、위장도반응、골수억제급조사야피부반응등독부반응엄중정도균현저저우대조조,차이유통계학의의(P<0.05)。결론복합보매보조치료비인암가유효감경방화료독부반응,대제고환자생활질량화치료내수성균유적겁의의。
Objective To explore the clinical effects of chemoradiotherapy toxic and side effect for the patients with nasopharynx cancer by coenzyme complex. Methods 80 cases of patients with nasopharynx cancer were randomly divided into experiment group and control group. The experiment group were treated by chemoradiotherapy combine with coenzyme complex, the control group were treated by chemoradiotherapy. The short-term effects and toxic and side effect were compared for the two groups. Results There was no significant difference on the clinical effects for the two groups(P>0.05); The oropharyngeal mucosa reaction, gastrointestinal reaction, myelosuppression, radiation skin reactions for the experiment group were lower than the control group(P < 0.05). Conclusion The clinical effects of chemoradiotherapy toxic and side effect for the patients with nasopharynx cancer by coenzyme complex is good, it can increase the living quality and tolerance.